Cargando…

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval

PURPOSE: Antipsychotic drugs have been implicated as risk factors for QT prolongation, which is a predictor of sudden cardiac death. However, the QT interval is considered an imperfect marker for proarrhythmic risk. Recently, improved methods, namely, QT dispersion (QTD), QTD ratio (QTDR), T wave pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Okayasu, Hiroaki, Shinozaki, Takahiro, Takano, Yumiko, Sugawara, Norio, Fujii, Kumiko, Yasui-Furukori, Norio, Ozeki, Yuji, Shimoda, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851579/
https://www.ncbi.nlm.nih.gov/pubmed/33542628
http://dx.doi.org/10.2147/NDT.S287042
_version_ 1783645657426296832
author Okayasu, Hiroaki
Shinozaki, Takahiro
Takano, Yumiko
Sugawara, Norio
Fujii, Kumiko
Yasui-Furukori, Norio
Ozeki, Yuji
Shimoda, Kazutaka
author_facet Okayasu, Hiroaki
Shinozaki, Takahiro
Takano, Yumiko
Sugawara, Norio
Fujii, Kumiko
Yasui-Furukori, Norio
Ozeki, Yuji
Shimoda, Kazutaka
author_sort Okayasu, Hiroaki
collection PubMed
description PURPOSE: Antipsychotic drugs have been implicated as risk factors for QT prolongation, which is a predictor of sudden cardiac death. However, the QT interval is considered an imperfect marker for proarrhythmic risk. Recently, improved methods, namely, QT dispersion (QTD), QTD ratio (QTDR), T wave peak-to-end interval (Tp-e), Tp-e/QT ratio and Tp-e/QTc ratio, have been regarded as proarrhythmic risk markers. We attempted to reevaluate the risk of sudden cardiac death due to antipsychotics use by measuring these improved evaluation methods. PATIENTS AND METHODS: We retrospectively evaluated QTc, QTD, QTDR, Tp-e, Tp-e/QT ratio and Tp-e/QTc ratio from the medical records of 410 patients with schizophrenia diagnosed by the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision, or 5th Edition. Information on drugs administered was obtained from medical records. We investigated the correlation between each index on ECG and medication, such as antipsychotics, prescribed to participants with linear regression analysis. We also compared each index between 235 healthy controls and 235 patients matched for age and sex. RESULTS: Positive correlations between QTc and levomepromazine and brexpiprazole were identified. Levomepromazine and lithium were positively correlated with QTD. Levomepromazine, quetiapine, asenapine, clozapine and carbamazepine were positively correlated with QTDR. Levomepromazine, olanzapine, brexpiprazole and lithium were positively correlated with Tp-e. Olanzapine, brexpiprazole and lithium were positively correlated with the Tp-e/QT ratio. Olanzapine, brexpiprazole and lithium were positively correlated with Tp-e/QTc ratio. Significant differences in all indexes were noted between the patients and healthy controls. CONCLUSION: According to our results, the prediction of the risk of sudden cardiac death by each index was inconsistent. We should evaluate the predictive factor of ventricular arrhythmia according to various electrocardiogram indexes because QTc alone could not identify the risk of sudden cardiac death.
format Online
Article
Text
id pubmed-7851579
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78515792021-02-03 Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval Okayasu, Hiroaki Shinozaki, Takahiro Takano, Yumiko Sugawara, Norio Fujii, Kumiko Yasui-Furukori, Norio Ozeki, Yuji Shimoda, Kazutaka Neuropsychiatr Dis Treat Original Research PURPOSE: Antipsychotic drugs have been implicated as risk factors for QT prolongation, which is a predictor of sudden cardiac death. However, the QT interval is considered an imperfect marker for proarrhythmic risk. Recently, improved methods, namely, QT dispersion (QTD), QTD ratio (QTDR), T wave peak-to-end interval (Tp-e), Tp-e/QT ratio and Tp-e/QTc ratio, have been regarded as proarrhythmic risk markers. We attempted to reevaluate the risk of sudden cardiac death due to antipsychotics use by measuring these improved evaluation methods. PATIENTS AND METHODS: We retrospectively evaluated QTc, QTD, QTDR, Tp-e, Tp-e/QT ratio and Tp-e/QTc ratio from the medical records of 410 patients with schizophrenia diagnosed by the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision, or 5th Edition. Information on drugs administered was obtained from medical records. We investigated the correlation between each index on ECG and medication, such as antipsychotics, prescribed to participants with linear regression analysis. We also compared each index between 235 healthy controls and 235 patients matched for age and sex. RESULTS: Positive correlations between QTc and levomepromazine and brexpiprazole were identified. Levomepromazine and lithium were positively correlated with QTD. Levomepromazine, quetiapine, asenapine, clozapine and carbamazepine were positively correlated with QTDR. Levomepromazine, olanzapine, brexpiprazole and lithium were positively correlated with Tp-e. Olanzapine, brexpiprazole and lithium were positively correlated with the Tp-e/QT ratio. Olanzapine, brexpiprazole and lithium were positively correlated with Tp-e/QTc ratio. Significant differences in all indexes were noted between the patients and healthy controls. CONCLUSION: According to our results, the prediction of the risk of sudden cardiac death by each index was inconsistent. We should evaluate the predictive factor of ventricular arrhythmia according to various electrocardiogram indexes because QTc alone could not identify the risk of sudden cardiac death. Dove 2021-01-27 /pmc/articles/PMC7851579/ /pubmed/33542628 http://dx.doi.org/10.2147/NDT.S287042 Text en © 2021 Okayasu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Okayasu, Hiroaki
Shinozaki, Takahiro
Takano, Yumiko
Sugawara, Norio
Fujii, Kumiko
Yasui-Furukori, Norio
Ozeki, Yuji
Shimoda, Kazutaka
Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
title Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
title_full Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
title_fullStr Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
title_full_unstemmed Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
title_short Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
title_sort effects of antipsychotics on arrhythmogenic parameters in schizophrenia patients: beyond corrected qt interval
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851579/
https://www.ncbi.nlm.nih.gov/pubmed/33542628
http://dx.doi.org/10.2147/NDT.S287042
work_keys_str_mv AT okayasuhiroaki effectsofantipsychoticsonarrhythmogenicparametersinschizophreniapatientsbeyondcorrectedqtinterval
AT shinozakitakahiro effectsofantipsychoticsonarrhythmogenicparametersinschizophreniapatientsbeyondcorrectedqtinterval
AT takanoyumiko effectsofantipsychoticsonarrhythmogenicparametersinschizophreniapatientsbeyondcorrectedqtinterval
AT sugawaranorio effectsofantipsychoticsonarrhythmogenicparametersinschizophreniapatientsbeyondcorrectedqtinterval
AT fujiikumiko effectsofantipsychoticsonarrhythmogenicparametersinschizophreniapatientsbeyondcorrectedqtinterval
AT yasuifurukorinorio effectsofantipsychoticsonarrhythmogenicparametersinschizophreniapatientsbeyondcorrectedqtinterval
AT ozekiyuji effectsofantipsychoticsonarrhythmogenicparametersinschizophreniapatientsbeyondcorrectedqtinterval
AT shimodakazutaka effectsofantipsychoticsonarrhythmogenicparametersinschizophreniapatientsbeyondcorrectedqtinterval